BioLife Solutions, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 119.16M | 76.24M | 75.86M | 82.25M | 96.21M | 17.0% | |
| Cost of Revenue | (90.31M) | (29.33M) | (96.52M) | (28.58M) | (34.10M) | 19.3% | |
Gross Profit | 28.85M | 46.91M | 46.75M | 53.67M | 62.12M | 15.7% | |
| Operating Expenses | |||||||
| Research & Development | (11.82M) | (14.80M) | (18.80M) | (7.91M) | (7.57M) | -4.4% | |
| Selling, General & Administrative | (48.09M) | (44.93M) | (55.97M) | (50.15M) | (55.37M) | 10.4% | |
| General & Administrative | (34.10M) | (33.26M) | (43.26M) | (40.54M) | (45.52M) | 12.3% | |
| Selling & Marketing | (14.00M) | (11.67M) | (12.71M) | (9.61M) | (9.85M) | 2.5% | |
| Depreciation & Amortization | (12.87M) | (19.96M) | (12.29M) | (8.66M) | (4.69M) | -45.9% | |
Operating Income (EBIT) | -35.16M | -5.92M | -23.44M | -7.13M | -1.08M | -84.8% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (485.00K) | (687.00K) | (1.81M) | (719.00K) | (2.71M) | 276.4% | |
| Other Income/Expenses (Net) | 6.13M | 1.07M | 4.97M | -4.30M | -11.00M | 156.1% | |
Income Before Tax | -29.03M | -4.85M | -18.47M | -11.43M | -12.08M | 5.7% | |
| Income Tax Expense | (20.12M) | (5.24M) | (24.00K) | (38.00K) | (49.00K) | -228.9% | |
Net Income | -8.91M | -139.81M | -66.43M | -20.18M | -12.13M | -39.9% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-0 | $-3 | $-2 | $-0 | $-0 | -43.2% | |
| Weighted Avg Shares Outstanding | 38.50M | 42.48M | 43.72M | 46.07M | 47.75M | 3.7% | |
| Weighted Avg Shares Outstanding (Diluted) | 38.50M | 42.48M | 43.72M | 46.07M | 48.65M | 5.6% | |
EBITDA | -16.65M | -124.18M | -45.24M | 1.53M | 3.61M | 135.4% |
Explore BLFS
BLFS in the Healthcare
Small Cap